Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Micro Chemical Initiative (MCI) is a Japanese technology company specializing in the development and commercialization of micro-chemical chip technology and micro-reactor systems. Founded as a venture from the University of Tokyo, the company provides advanced microfluidic solutions for chemical synthesis, drug discovery, and clinical diagnostics. Their products enable high-efficiency, high-precision chemical reactions and analysis on a microscopic scale, significantly reducing reagent consumption and reaction times. MCI serves a global clientele in the pharmaceutical, chemical, and environmental sectors, offering both standardized hardware and custom-designed micro-chips. The company's core expertise lies in the integration of complex chemical processes into compact, automated 'Lab-on-a-Chip' platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Micro Chemical Initiative.